Free Trial

Iovance Biotherapeutics (IOVA) Insider Trading & Ownership

Iovance Biotherapeutics logo
$8.14 -0.05 (-0.61%)
(As of 11/20/2024 ET)

Iovance Biotherapeutics (NASDAQ:IOVA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.10%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$2.29 M
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$503,000.00
Get IOVA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Iovance Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

IOVA Insider Buying and Selling by Quarter

Iovance Biotherapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/12/2024Ryan D MaynardDirectorSell50,000$10.06$503,000.00  
2/20/2024Merrill A McpeakDirectorBuy250,000$9.15$2,287,500.00  
(Data available from 1/1/2013 forward)

IOVA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Iovance Biotherapeutics includes Frederick G Vogt, Iain D Dukes, Merrill A Mcpeak, Ryan D Maynard, and Wayne P Rothbaum. Learn more on insiders at IOVA.

12.10% of Iovance Biotherapeutics stock is owned by insiders. Learn more on IOVA's insider holdings.

The following insiders have purchased IOVA shares in the last 24 months: Frederick G Vogt ($5,980.00), Iain D Dukes ($61,000.00), Merrill A Mcpeak ($2,466,400.00), and Wayne P Rothbaum ($91,500,000.00).

Insiders have purchased a total of 15,291,000 IOVA shares in the last 24 months for a total of $94,033,380.00 bought.

The following insider sold IOVA shares in the last 24 months: Ryan D Maynard ($503,000.00).

Insiders have sold a total of 50,000 Iovance Biotherapeutics shares in the last 24 months for a total of $503,000.00 sold.

Iovance Biotherapeutics Key Executives

  • Dr. Frederick G. Vogt Esq. (Age 50)
    J.D., Ph.D., Interim CEO, President, General Counsel & Corporate Secretary
    Compensation: $1.39M
  • Mr. Jean-Marc Bellemin M.B.A. (Age 51)
    CFO, Principal Accounting Officer & Treasurer
    Compensation: $932.2k
  • Dr. Igor P. Bilinsky (Age 51)
    Chief Operating Officer
    Compensation: $932.2k
  • Dr. Friedrich Graf Finckenstein M.D. (Age 57)
    Chief Medical Officer
    Compensation: $1.06M
  • Ms. Sara Pellegrino
    Vice President of Investor Relations & Public Relations
  • Ms. Tracy Winton
    Senior Vice President of Human Resources
  • Mr. Howard B. Johnson M.B.A. (Age 64)
    Chief Business Officer
  • Mr. James Ziegler M.B.A.
    Executive Vice President of Commercial
  • Dr. Raj K. Puri M.D.
    Ph.D., Executive VP of Regulatory Strategy & Translational Medicine
  • Mr. Brian Shew M.B.A.
    Senior VP & Head of Digital and Information Technology


This page (NASDAQ:IOVA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners